|
|
Blood, 15 June 2006, Vol. 107, No. 12, pp. 4930-4937.
Prepublished online as a Blood First Edition Paper on February 23, 2006; DOI 10.1182/blood-2005-10-4144.
Previous Article | Next Article 
Submitted October 18, 2005
Accepted February 2, 2006
IL-10-producing macrophages preferentially clear early apoptotic cells
Wei Xu, Anja Roos, Nicole Schlagwein, Andrea M Woltman, Mohamed R Daha, and Cees van Kooten*
Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands
* Corresponding author; email: kooten{at}lumc.nl.
Efficient clearance of apoptotic cells seems to be a prerequisite to prevent the development of autoimmunity. Here we identify that M-CSF-driven macrophages (M 2) are potent phagocytes that have the unique capacity to preferentially bind and ingest early apoptotic cells. This macrophage subset has intrinsic anti-inflammatory properties, characterized by high IL-10 production in the absence of pro-inflammatory cytokines, such as IL-6 and TNF- . Importantly, whereas the IL-6 and TNF- production by GM-CSF-driven macrophages (M 1) is inhibited upon uptake of apoptotic cells, the anti-inflammatory status of M 2 is retained during phagocytosis. M 2 were shown to use CD14 to tether apoptotic cells, whereas recognition of phosphatidylserine (PS) contributed to uptake of early apoptotic cells. M 2 showed more potent macropinocytosis compared to DCs and M 1, and uptake of apoptotic cells was inhibited by a macropinocytosis inhibitor. Our studies suggest that, under steady-state conditions, IL-10-producing M 2 are prominently involved in the clearance of early apoptotic cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Xu, S. P. Berger, L. A. Trouw, H. C. de Boer, N. Schlagwein, C. Mutsaers, M. R. Daha, and C. van Kooten
Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation
J. Immunol.,
June 1, 2008;
180(11):
7613 - 7621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nishimura, S. Takahashi, H. Kamikatahira, Y. Kuroki, D. E. Jaalouk, S. O'Brien, E. Koivunen, W. Arap, R. Pasqualini, H. Nakayama, et al.
Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells
J. Biol. Chem.,
April 25, 2008;
283(17):
11752 - 11762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Landi, L. A. Babiuk, and S. van Drunen Littel-van den Hurk
High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer
J. Leukoc. Biol.,
October 1, 2007;
82(4):
849 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Trouw, A. A. Bengtsson, K. A. Gelderman, B. Dahlback, G. Sturfelt, and A. M. Blom
C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack
J. Biol. Chem.,
September 28, 2007;
282(39):
28540 - 28548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barrett, C. Dai, J. Gamberg, M. Gallant, and M. Grant
Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10
J. Leukoc. Biol.,
July 1, 2007;
82(1):
152 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Kwan, C. Boix, N. Gougelet, W. H. Fridman, and C. G. F. Mueller
LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors
J. Leukoc. Biol.,
July 1, 2007;
82(1):
133 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
J. Exp. Med.,
May 14, 2007;
204(5):
1057 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |